- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 4 - Pushing Reform through Immunotherapy
As the panelists explore the costs and value of genomic precision therapy and immunotherapy, Michael Kolodziej, MD, explains that multiple factors should be considered when determining the cost of care for a cancer patient. For instance, he believes that 30% of total healthcare costs for cancer patients is wastefully spent.
While curative immunotherapy is still not quite on the table, clinicians have already witnessed a “plateau of survival” for melanoma patients treated with ipilimumab, as explained by Jeffrey Weber, MD, PhD.
Dr Weber agrees that wasteful spending is a concern, and as he explains that survival is the ultimate goal for cancer treatment, he and Dr Kolodziej conclude that reimbursement models need to be addressed to eliminate wasteful spending, identify value, and provide meaningful outcomes.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
